[On the problem of the thrombolytic effect of heparin and nicotinic acid].
D000818:Animals; D000991:Antithrombins; D002415:Cats; D005263:Femoral Artery; D005340:Fibrinogen; D005343:Fibrinolytic Agents; D006493:Heparin / Q000627:therapeutic use*; D006496:Heparinoids / Q000627:therapeutic use*; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010958:Plasminogen; D013916:Thrombelastography; D013917:Thrombin / Q000494:pharmacology; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology
D000991:Antithrombins; D005343:Fibrinolytic Agents; D006496:Heparinoids; D009539:Nicotinic Acids; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D013917:Thrombin
Zur Frage der thrombolytischen Wirkung von Heparin und Nikotinsäure.